BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8657224)

  • 41. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of immunotherapy in allergic rhinitis/allergic asthma.
    Creticos PS
    Allergy Proc; 1995; 16(6):297-302. PubMed ID: 8747314
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of an alum precipitated mixed ragweed antigen: a three-year study.
    Lazar H; Loeffler JA
    Ann Allergy; 1970 May; 28(5):214-20. PubMed ID: 4115723
    [No Abstract]   [Full Text] [Related]  

  • 44. [Interest of allergology evaluation for the treatment of asthma and rhinosinusitis].
    Michel O
    Rev Med Brux; 2008 Sep; 29(4):393-9. PubMed ID: 18949994
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Desensitization in 469 cases of bronchial asthma alone or with other allergic syndromes. Results obtained in our allergy polyclinic, 1965-1970].
    Tekül N; Akkor A; Sevan S
    Turk Tip Cemiy Mecm; 1972 Dec; 38(12):509-26. PubMed ID: 4668359
    [No Abstract]   [Full Text] [Related]  

  • 46. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.
    Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR
    J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.
    Omnes LF; Bousquet J; Scheinmann P; Neukirch F; Jasso-Mosqueda G; Chicoye A; Champion L; Fadel R
    Eur Ann Allergy Clin Immunol; 2007 May; 39(5):148-56. PubMed ID: 17626329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The treatment of pollinosis with small doses of emulsions of ironated ragweed extract.
    Prigal SJ; Stern A; Avedon AB; Franklin HL; Hilton DW; Furman ML
    Ann Allergy; 1965 Sep; 23(9):414-21. PubMed ID: 5830237
    [No Abstract]   [Full Text] [Related]  

  • 49. [Allergic rhinitis. This year the pollen count is expected to be high].
    Hellmann A
    MMW Fortschr Med; 2006 May; 148(21):51-2. PubMed ID: 16796189
    [No Abstract]   [Full Text] [Related]  

  • 50. [Procedure of desensitization with microbe allergens in bronchial asthma and rhinosinusopathy of infectious allergic nature].
    Sidorenko EN
    Zh Ushn Nos Gorl Bolezn; 1969; 29(5):67-72. PubMed ID: 5396724
    [No Abstract]   [Full Text] [Related]  

  • 51. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
    Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Desensitization for those afflicted with hay fever. With 4 pricks hyposensitized to pollen].
    MMW Fortschr Med; 2004 Mar; 146(11):58. PubMed ID: 15152778
    [No Abstract]   [Full Text] [Related]  

  • 54. Seasonal changes of proapoptotic soluble Fas ligand level in allergic rhinitis combined with asthma.
    Mezei G; Lévay M; Sepler Z; Héninger E; Kozma GT; Cserháti E
    Pediatr Allergy Immunol; 2006 Sep; 17(6):444-9. PubMed ID: 16925690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule.
    Colás C; Monzón S; Venturini M; Lezaun A
    J Allergy Clin Immunol; 2006 Apr; 117(4):810-6. PubMed ID: 16630938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R; Panzani RC; Mistrello G
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Allergic rhinitis and asthma. Fine particulate matter makes pollen more aggressive].
    Barczok M
    MMW Fortschr Med; 2007 May; 149(21):37-8. PubMed ID: 17668732
    [No Abstract]   [Full Text] [Related]  

  • 58. Co-seasonal desensitization of pollinosis with the scarification-method of Blamoutier.
    Eichenberger H; Storck H
    Acta Allergol; 1966; 21(3):261-7. PubMed ID: 5953419
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunotherapy in children: past, present, and future. (Part I).
    Johnstone DE
    Ann Allergy; 1981 Jan; 46(1):1-7. PubMed ID: 6161571
    [No Abstract]   [Full Text] [Related]  

  • 60. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
    Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
    Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.